<code id='5C9EEA6509'></code><style id='5C9EEA6509'></style>
    • <acronym id='5C9EEA6509'></acronym>
      <center id='5C9EEA6509'><center id='5C9EEA6509'><tfoot id='5C9EEA6509'></tfoot></center><abbr id='5C9EEA6509'><dir id='5C9EEA6509'><tfoot id='5C9EEA6509'></tfoot><noframes id='5C9EEA6509'>

    • <optgroup id='5C9EEA6509'><strike id='5C9EEA6509'><sup id='5C9EEA6509'></sup></strike><code id='5C9EEA6509'></code></optgroup>
        1. <b id='5C9EEA6509'><label id='5C9EEA6509'><select id='5C9EEA6509'><dt id='5C9EEA6509'><span id='5C9EEA6509'></span></dt></select></label></b><u id='5C9EEA6509'></u>
          <i id='5C9EEA6509'><strike id='5C9EEA6509'><tt id='5C9EEA6509'><pre id='5C9EEA6509'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:entertainment    Page View:2

          The Senate has set its eyes on regulating insurance plans for some of the most vulnerable patients in the U.S. — the 12.5 million people eligible for both Medicare and Medicaid.

          “They’re a complex group of people with a lot of chronic conditions — mental illness, frailty, disability,” said Jose Figueroa, an internal medicine physician and health policy expert at Brigham and Women’s Hospital. Over a third of these dual-eligible beneficiaries have less than a high school education, and about 90% make less than $20,000 per year.

          advertisement

          Just around 15% of beneficiaries are eligible for both Medicare and Medicaid, but they account for a third of these programs’ spending — around $440 billion — and still don’t receive better health care, Sen. Bill Cassidy (R-La.) pointed out in a JAMA viewpoint published earlier this month. “The root cause of worse outcomes despite spending more money is a lack of coordination of care,” Cassidy wrote.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          leisure time

          Psychedelics group wrestles with new pharma identity
          Psychedelics group wrestles with new pharma identity

          OliviaGoldhill/STATDENVER—Hecouldhavebeenarockstar,areligiousicon,thewayecstaticapplausefromthousand

          read more
          Welsh Carson private equity firm escapes from FTC antitrust case
          Welsh Carson private equity firm escapes from FTC antitrust case

          AjudgeruledthatWelshCarsonwon'thavetofaceantitrustallegationsaboutitsanesthesiologypractice.AdobeWel

          read more
          Trump demands the U.S. pay no more for drugs than other countries … again
          Trump demands the U.S. pay no more for drugs than other countries … again

          EthanMiller/GettyImagesWASHINGTON—FormerPresidentTrumpisbacktocampaigningfortyingMedicaredrugpricest

          read more

          New documents shed light on MD Anderson Cancer Institute feud

          AdobeEarlylastyear,MDAndersonCancerCenterleadershiphadaproblemontheirhands:acontentiousdisputebetwee